rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

16 Jul,15:29
2602.25
49.45 (1.94%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL
15,175 2,552.80 2,688.70 - 2,535.15 2,759.00 - 1,376.50 44,083.69
NSE | BSE

GlaxoSmithKline Pharmaceuticals Ltd.

GLAXO

16 Jul,15:59
2619.75
67.20 (2.63%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL
177,660 2552.55 2,690.00 - 2,543.00 2,760.00 - 1,377.25 4,664.55
(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,407.253,216.343,217.513,193.733,224.68
Operating profit900.65799.41755.83694.95658.45
Interest1.801.811.993.536.34
Gross profit1,022.33899.12830.06801.61729.67
EPS (Rs)34.5135.8799.7921.116.50

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

DLF Expands...
DLF Expands Housing & Commercial Biz, Enters Mumbai & Goa
Real estate giant DLF is expanding its residential and commercial property portfolio, entering new markets like Mumbai and Goa. Chairman Rajiv Singh outlines the company's growth strategy and...
Jul 17, 2024 15:56
BSE Midcap,...
BSE Midcap, Smallcap Stocks Surge: Gains, Reasons & Outlook
BSE midcap and smallcap indices have surged this year, driven by strong domestic liquidity and positive macroeconomic fundamentals. Experts highlight the role of sector-specific strengths,...
Jul 17, 2024 15:49
LIC & SBI...
LIC & SBI Outperform: Infrastructure Exposure Drives Growth
LIC and SBI's stock performance surpasses peers due to heavy investment in India's infrastructure sector, while private players focus on tech and consumer sectors. Learn why infrastructure exposure...
Jul 17, 2024 15:17
Citroen e-C3: 500...
Citroen e-C3: 500 EVs for Refex Green Mobility
Citroen India signs MoU with Refex Green Mobility to procure 500 e-C3 electric vehicles, marking a major step towards sustainable mobility in South India.
Jul 17, 2024 15:08
Cropin Launches...
Cropin Launches AI-Powered Agri-Intelligence Platform 'Sage'
Cropin Technology launches 'Sage', an AI-powered platform providing real-time agricultural intelligence for improved crop production planning and resilient supply chains.
Jul 17, 2024 15:05

More News »

Top News

DLF Expands...
DLF Expands Housing & Commercial Biz, Enters Mumbai & Goa
Real estate giant DLF is expanding its residential and commercial property portfolio, entering new markets like Mumbai and Goa. Chairman Rajiv Singh outlines the company's growth strategy and...
Jul 17, 2024 15:56
Delhi Industrial...
Delhi Industrial Areas Revamp: Government to Bear 90% Cost
Delhi Industries Minister Saurabh Bharadwaj met factory owners to discuss plans to revamp 27 industrial areas. The government will bear 90% of the cost for development.
Jul 17, 2024 15:50
BSE Midcap,...
BSE Midcap, Smallcap Stocks Surge: Gains, Reasons & Outlook
BSE midcap and smallcap indices have surged this year, driven by strong domestic liquidity and positive macroeconomic fundamentals. Experts highlight the role of sector-specific strengths,...
Jul 17, 2024 15:49
LIC & SBI...
LIC & SBI Outperform: Infrastructure Exposure Drives Growth
LIC and SBI's stock performance surpasses peers due to heavy investment in India's infrastructure sector, while private players focus on tech and consumer sectors. Learn why infrastructure exposure...
Jul 17, 2024 15:17
Citroen e-C3: 500...
Citroen e-C3: 500 EVs for Refex Green Mobility
Citroen India signs MoU with Refex Green Mobility to procure 500 e-C3 electric vehicles, marking a major step towards sustainable mobility in South India.
Jul 17, 2024 15:08

More Top News »

Report Card

PE Ratios
75.40
EPS (Rs.)
34.51
Sales (Rs. Cr)
910.87
Face Value (Rs.)
10
Net Profit Margin (%)
17.16
Last Bonus
1:1
Last Dividend(%)
320
Return on Average Equity
32.6

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

announcement Board Meeting Intimation for Un-Audited Financial Results For The First Quarter Ended 30Th June 2024 - 4 hour(s) ago
announcement Announcement under Regulation 30 (LODR)-Change in Management - 05 Jul 2024

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,585.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,575.35
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,187.90
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,792.80
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,951.25
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,442.75
  • Compare
  • Max Healthcare Institute Ltd.
  • 920.90
  • Compare
  • Alkem Laboratories Ltd.
  • 5,383.05
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Hello sir, I am 23 years old, just graduated and...

I am getting restricted refund in bank amount will...

I have mutual fund of 1cr and equity of 60 lacsFd of...

Hi I am 27 years old. Currently I am working abroad....

Dear Sh.Vivek Ji - I am aged 45, unmarried. I am an...

Hello Col.I am 34 years old, monthly salary is 1...

More REDIFFGURUS

RediffGurus

Money question

I am in a big debt trap. Have credit card...

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
GlaxoSmithKline Pharmaceuticals Ltd.
Share Price » Fundamentals » Financial » Technicals » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close